TransMedics Group, Inc. (TMDX) Revenue Growth
TransMedics Group, Inc. (TMDX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | 8.62% |
| 2021-12-31 | 18.03% |
| 2022-12-31 | 208.83% |
| 2023-12-31 | 158.53% |
| 2024-12-31 | 82.74% |
| 2025-12-31 | 37.13% |
How TMDX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| KRYS | Krystal Biotech Inc. | 33.94% |
| PODD | Insulet Corporation | 30.73% |
| AXGN | Axogen Inc. | 20.21% |
| RARE | Ultragenyx Pharmaceutical Inc. | 20.18% |
| ENSG | The Ensign Group Inc. | 18.72% |
These are five companies in the same sector as TMDX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TransMedics Group, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("TMDX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMDX | $85.22 | +1.10% | 0.07M |
| 3 | ||||
| 4 | ||||
| 5 |